Planned exploratory (secondary) analysis of a phase 2 migraine trial (40 of 50 analysed): biofeedback-assisted relaxation improved 6-month quality of life vs enhanced usual care mainly in those with more body worry, poorer self- or emotion regulation, or low exercise enjoyment.
Secondary analysisn = 50
Szuhany et al. Predictors of response to biofeedback-assisted relaxation for migraine: An exploratory analysis